Abstract: ABSTRACT: BACKGROUND: We analyse magnesium levels in amniotic fluid to establish normal values for the 14th to 18th week of pregnancy and establish critical values that could be useful diagnostic and therapeutic guidelines for possible complications. Findings: Ninety-two samples of amniotic fluid obtained by amniocentesis as well as the corresponding serum samples of pregnant women were analysed. The gestational age (mean +/- SD) at which the amniotic fluid sample was obtained was 16.13 +/- 1.87 weeks. Magnesium levels were determined by colorimetric assay with chlorophosphonazo-III using the the Cobas c 501 analyser (Roche Diagnostics). Statistical treatment of data was performed using the SPSS program, version 15.0. Results revealed a mean magnesium value of 1.65 +/- 0.16 mg/dL in amniotic fluid and 1.97 +/- 0.23 mg/dL in serum. Conclusions: It would be interesting to extend the study to a larger number of pregnant women to determine variations in normal magnesium values in the three trimesters of pregnancy.
Abstract: OBJECTIVE: To determine the influence of age, training status, race time, and exercise intensity on the appearance of cardiac biomarkers after a cycle-touring event. DESIGN: Pre-post exercise measurements. SETTING: University of Zaragoza, Zaragoza, Spain. PARTICIPANTS: Ninety-one amateur cyclists. INTERVENTION: The 2005 Quebrantahuesos cycle-touring event (distance: 206 km; altitude difference: 3800 m). MAIN OUTCOME MEASURES: Cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) were measured the day before and immediately after the race. Heart rate (HR) monitoring was performed on 55 cyclists during the race to evaluate exercise intensity. RESULTS: cTnI and NT-pro-BNP were significantly elevated immediately post race, with 43% of participants exhibiting cTnI levels greater than 0.04 microg/L and 65% of the participants measuring NT-pro-BNP levels greater than 125 ng/L. The cTnI increase was significantly associated with mean exercise intensity HR (r = 0.36, P < 0.01) but was not associated with age, training status, or race time. The increase in NT-pro-BNP correlated with race time (r = 0.40, P < 0.001) and training status (r = -0.36, P < 0.001) but was not associated with age or exercise intensity HR measures. CONCLUSIONS: These results suggest that, in part, exercise intensity (HR) is responsible for the cTnI increase and that race time is responsible for the increase in NT-pro-BNP. Future standardized endurance exercise trials are recommended to further elucidate the potentially differential effects of training status, exercise time, and intensity on post-exercise increases in cTnI and NT-pro-BNP.
Abstract: Numerous studies have observed cardiac biomarker release with prolonged exercise. Despite this, we are unsure as to the constituent aspects of any given exercise bout that may be important in promoting cardiac biomarker release. This study examined the influence of exercise duration and intensity on the appearance of cardiac biomarkers. Twenty-one subjects ran for 45, 90 and 180 min at 85% and 95% of their individual anaerobic threshold on six different days randomized. Cardiac troponin I (cTnI) and N-terminal pro-brain natiuretic peptide (NT-proBNP) were assayed from blood samples collected before, 30 min and 3 h post-exercise. NT-proBNP was elevated after all exercise trials (range before: 21-32; range post: 38-67 ng/L). Peak post-exercise concentrations of NT-proBNP were associated with exercise duration (P=0.049), but not exercise intensity (P=0.451). cTnI was elevated after all exercise trials (range before: 0.007-0.011; range post: 0.008-0.021 mug/L). Peak post-exercise concentrations of cTnI were associated with exercise duration (P=0.003) and intensity (P=0.037). Data suggest that while both cTnI and NT-proBNP increased after all exercise trials, the mediating effect of duration influenced both NT-proBNP and cTnI while intensity influenced only cTnI.
Abstract: ABSTRACT: BACKGROUND: : Thyroid function changes during pregnancy and maternal thyroid dysfunction have been associated with adverse outcomes. Our aim was to evaluate thyroid hormones levels in pregnant women resident in Aragon, Spain. FINDINGS: Samples for 1198 pregnant women with no apparent thyroid disorders were analyzed, using paramagnetic microparticle and chemiluminescent detection technologies, in order to determine levels of thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (Tg-Ab). Of the women in our sample, 85.22% had normal values for TPO-Ab and Tg-Ab and 14.77% had results revealing the presence of autoimmune diseases of the thyroid. The thyroid hormone reference values obtained according to gestational age (in brackets) were as follows: for free T3, values were 3.38+/-0.52 pg/mL (<11 weeks), 3.45+/-0.54 pg/mL (11-20 weeks), 3.32+/-0.43 pg/mL (21-30 weeks), 3.21+/-0.53 pg/mL (31-36 weeks), and 3.23+/-0.41 pg/mL (>36 weeks); for free T4, values were 1.10+/-0.14 ng/dL (<10 weeks), 1.04+/-0.14 ng/dL (11-20 weeks), 0.93+/-0.12 ng/dL (21-30 weeks), 0.90+/-0.13 ng/dL (31-36 weeks), and 0.80+/-0.21 ng/dL (>36 weeks); and for TSH, values were (mcIU/mL): 1.12+/-0.69 (<10 weeks), 1.05+/-0.67 (11-20 weeks), 1.19+/-0.60 (21-30 weeks), 1.38+/-0.76 (31-36 weeks), and 1.46+/-0.72 (>36 weeks). CONCLUSION: Pregnant women with normal antibody values according to gestational age had values for FT4 and TSH, but not for FT3, that differed to a statistically significant degree. The values we describe can be used as reference values for the Aragon region of Spain.
Abstract: OBJECTIVE: We propose a comparative study of urinary cortisol in a controlled simple group of patients diagnosed with fibromyalgia (FM) during a minimum time frame (3 years) vs. a normal group with the same characteristics of age and gender. Our objective is to demonstrate if urinary cortisol at lower levels than those found in the normal population, as long as FM is regarded, could help to evaluate the fatigue. METHODS: We determined the urinary cortisol in a group of 47 women with a clinical diagnosis of FM using the criteria from the American College of Rheumatology (ACR) 1990, with ages between 29 and 64 years, in whom an accurate sample was collected and cortisol was determined using an FPIA method. The results were compared with the urinary cortisol obtained in a group of 88 healthy women within the same age range as those with FM. RESULTS: Urinary cortisol in FM was 65.0mug/l (median), which was significantly lower than that of the healthy group (80.0mug/l), p<0.001. CONCLUSION: 33.4% of patients with FM displayed urinary cortisol concentrations significantly lower than the group of women without FM.
Abstract: ABSTRACT: BACKGROUND: Adynamia in fibromyalgia (FM) may be an expression of a functional deficit of the hypothalamic-pituitary-adrenal axis and be associated with below-normal levels of urinary cortisol. Our aim was to demonstrate that urinary cortisol was lower in patients with FM than in healthy subjects. FINDINGS: We measured urinary cortisol levels for a sample of 47 women aged 29 to 64 years (mean age 53 years), diagnosed with FM 2-3 years previously, and compared the results with those for a control sample of 58 healthy women of a similar age. Samples of 24-hour urine were appropriately collected and levels of urinary cortisol were measured using the fluorescence polarization immunoassay method. The mean cortisol value for the women with FM was 65.40 +/- 27.10 mug/L, significantly lower than the mean cortisol level for the control group, at 90.83 +/- 38.17 mug/L (p < 0.001). CONCLUSION: Our study confirms that women with FM have significantly lower urinary cortisol levels than healthy women.
Abstract: Serum Mg is an important biochemical parameter in the context of clinical medicine for monitoring patients and for helping to diagnose some pathologies. The clinical laboratories must offer analytical results of quality in all parameters determined, demonstrating this way the laboratory "skill competence". The aim of this study was to revalidate (ISO 15189 standard) some different colorimetric methods for Mg determination in serum used in clinical and/or biochemical laboratories in four hospitals in Spain, on the basis of results of interlaboratory comparison programmes: Bio-Rad EQAS and external quality control SEQC. Precision and inaccuracy were estimated by analysis of records of an external quality control programme for Mg. The precision and inaccuracy values obtained were both less than 10%, except in one hospital in which the precision was less than 15%. These values of precision and inaccuracy obtained may be considered highly satisfactory taking into account the validation requirement for these ones: less than 10%. These findings demonstrate the effectiveness of the new revalidation methodology for diagnostic methods in medicine, which does not require any disruption of the laboratory's routine activity and which can be used even if the method in question has not been validated previously. It is also suggested that the ideas and requirements of ISO 15189 should be followed by the research laboratories.
Abstract: Stricter regulations and controls for environmental lead have resulted in significantly lower frequency and reduced severity of chronic and acute lead intoxication. The aim of the present study was to update established reference ranges for lead in whole blood of healthy adults residing in Zaragoza and its region in northeastern Spain. The mean blood level was 2.94 +/- 2.02 microg/dl, with a median of 2.43 microg/dl (n = 156). For women, the mean was 2.29 +/- 1.64 microg/dl (n = 73) and for men 3.51 +/- 2.16 microg/dl (n = 83). The difference between genders is statistically significant (p < 0.005). Our results confirm an ongoing decline in blood lead levels in the studied region, which in 1989 were found to average 13.17 +/- 3.47 microg/dl. In addition, there is a clear need to take into account gender differences when defining normal ranges for lead.
Abstract: ISO 15189 standard establishes a requirement to periodically revalidate analytical methods for the determination of trace elements like Pb in blood, as conditions change and technical advances are made. The aim of this study was to revalidate an electrothermal atomic absorption spectrometry (ETAAS) method for determination of Pb in blood over the microrange 25-35 microg/dL, on the basis of historical results of interlaboratory comparison programmes. Precision and inaccuracy were estimated by analysis of records of an external quality control programme for Pb (PICC-PbS). The precision and inaccuracy values obtained were both less than 5%, highly satisfactory in view of the validation requirement that precision and inaccuracy be less than 10%. These findings demonstrate the effectiveness of this new validation methodology, which does not require any disruption of the laboratory's routine activity, and which can be used even if the method in question has not been validated previously at that laboratory.
Abstract: Selenium, copper and zinc status is important in pregnant women. The aim of this study was to establish updated normal ranges for these elements in serum of pregnant women from the Spanish region of Aragon, and to study variation in levels with respect to gestational period and maternal age. The study group consisted of 159 pregnant women who did not suffer from serious pathologies. These samples were classified into four gestational-period groups. Zn and Cu determinations were obtained by flame atomic absorption spectroscopy in a Perkin-Elmer 1100B apparatus, and Se was determined by electrothermal atomic absorption spectrometry with Zeeman correction, in a Perkin-Elmer 4110 ZL apparatus. The concentrations of Cu, Zn and Se averaged 73.61+/-43.67 microg/dL, 65.37+/-12.87 microg/dL and 99.59+/-21.74 microg/L, respectively. The Cu/Zn ratio increased from first trimester to the third trimester (2.07-3.49). There was no significant correlation between Zn and Se levels, but a significant correlation was found between Cu and Se levels (p<0.05) and between Cu and Zn levels (p<0.001). Serum Zn and Se levels decreased over gestation, while serum Cu concentrations increased; in all cases the variation occurred mostly in the first 3 or 4 months, with mean levels then remaining fairly stable until the end of pregnancy. Maternal age did not influence levels of any of the three metals.
